domenica, 3 maggio 2026

Notizie AIOM – anno XVII

21 Ottobre 2019

ASCO Survey: E-Cigarettes Are Widely Misperceived as Harmless Among Young Adults

October 19, 2019 - Findings from a national survey show that vaping is not only more common but also more favorably perceived among younger age groups than older adults, with 1 in 4 young people indicating their belief that vapes are “harmless” and not addictive. ...
Leggi tutto

21 Ottobre 2019

Statement on continued progress enhancing patient access to high-quality, low-cost generic drugs

October 16, 2019 - Affordable access to medicines is a public health concern and more generic drug competition can help reduce prices, improve access and benefit the public health. Safe, effective and high-quality generic drugs play a vital role in our health care system. ...
Leggi tutto

21 Ottobre 2019

Baby powder manufacturer voluntarily recalls products for asbestos

October 18, 2019 - The U.S. Food and Drug Administration is alerting consumers of a voluntary recall by Johnson & Johnson of Johnson’s Baby Powder after FDA testing has found that a sample from one lot of the product contains chrysotile fibers, a type of asbestos. ...
Leggi tutto

21 Ottobre 2019

FDA Label Update Supports Earlier Use of Romiplostim for ITP

October 18, 2019 - The FDA has approved a supplemental Biologics License Application (sBLA) for romiplostim, updating its label to include data demonstrating sustained platelet responses in adults with immune thrombocytopenia (ITP). Romiplostim is approved for the treatment ...
Leggi tutto

21 Ottobre 2019

European Network of Paediatric Research at EMA elects new chair

October 14, 2019 - The European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) has elected Pirkko Lepola of the Finnish Investigators Network for Pediatric Medicines (FinPedMed) as the new chair of its Coordinating Group. Mrs Lepola will co-chair ...
Leggi tutto

14 Ottobre 2019

11 ottobre 2019 – Atti degli Organismi indipendenti di valutazione – aggiornamento sezione

14 Ottobre 2019

11 ottobre 2019 – Prossima pubblicazione determinazione nuova indicazione terapeutica Brentuximab vedotin (Takeda) ed eliminazione MEA

14 Ottobre 2019

11 ottobre 2019 – Comunicazione ai titolari di AIP sulla dichiarazione di accettazione da parte della QP

14 Ottobre 2019

11 ottobre 2019 – Comunicazione ai titolari di AIP sulla traduzione certificata

14 Ottobre 2019

NICE Approves Maintenance Rucaparib for Relapsed Ovarian Cancer

Oct 11, 2019 - The UK’s National Institute for Health and Care Excellence (NICE) has approved rucaparib for the maintenance treatment of patients with relapsed ovarian, fallopian tube, or peritoneal cancer that has responded to platinum-based chemotherapy. The decision ...
Leggi tutto